Miller Anestesia

910 / 2894

Perioperative Ischemia Research Group. N Engl J
Med 335:1713–1720, 1996.
180. Poldermans D, Boersma E, Bax JJ, et al: The effect
of bisoprolol on perioperative mortality and myo-
cardial infarction in high-risk patients undergoing
vascular surgery. Dutch Echocardiographic
Cardiac Risk Evaluation Applying Stress Echocar-
diography Study Group. N Engl J Med 341:1789–
1794, 1999.
181. Lindenauer PK, Pekow P, Wang K, et al: Periopera-
tive beta-blocker therapy and mortality after major
noncardiac surgery. N Engl J Med 353:349–361,
2005.
182. Juul AB,Wetterslev J, Gluud C, et al: Effect of perio-
perative beta blockade in patients with diabetes
undergoing major non-cardiac surgery: Randomi-
sed placebo controlled, blinded multicentre trial.
BMJ 332:1482, 2006.
183. Yang H, Raymer K, Butler R, et al: The effects of
perioperative beta-blockade: Results of the Meto-
prolol after Vascular Surgery (MaVS) study, a ran-
domized controlled trial. Am Heart J 152:983–990,
2006.
184. Naylor CD, Sibbald WJ, Sprung CL, et al: Pulmo-
nary artery catheterization: Can there be an inte-
grated strategy for guideline development and
research promotion? JAMA 269:2407, 1993.
185. Hollinger I: Diseases of the cardiovascular system.
In Katz R, Steward D (eds): Anesthesia and Uncom-
mon Pediatric Diseases.Philadelphia,WB Saunders,
1993, p 93.
186. Wilson W, Taubert KA, Gewitz M, et al: Prevention
of infective endocarditis: Guidelines from the Ame-
rican Heart Association: A guideline from the
American Heart Association Rheumatic Fever,
Endocarditis, and Kawasaki Disease Committee,
Council on Cardiovascular Disease in the Young,
and the Council on Clinical Cardiology, Council on
Cardiovascular Surgery and Anesthesia, and the
Quality of Care and Outcomes Research Interdisci-
plinaryWorking Group.Circulation 116:1736–1754,
2007.
187. Nishimura RA,Carabello BA,Faxon DP,et al:ACC/
AHA 2008 guideline update on valvular heart
disease: Focused update on infective endocarditis:
A report of the American College of Cardiology/
American Heart Association Task Force on Prac-
tice Guidelines: Endorsed by the Society of Cardio-
vascular Anesthesiologists, Society for Cardiovas-
cular Angiography and Interventions, and Society
of Thoracic Surgeons. Circulation 118:887–889,
2008.
188. Katholi RE, Nolan SP, McGuire LB: Living with
prosthetic heart valves. Subsequent noncardiac
operations and the risk of thromboembolism or
hemorrhage. Am Heart J 92:162–167, 1976.
189. Bonow RO, Carabello B, de Leon AC Jr, et al: Gui-
delines for the management of patients with valvu-
lar heart disease: Executive summary. A report of
the American College of Cardiology/American
Heart Association Task Force on Practice Guideli-
nes (Committee on Management of Patients with
Valvular Heart Disease). Circulation 98:1949–1984,
1998.
190. Ezekowitz MD: Anticoagulation management of
valve replacement patients. J Heart Valve Dis
11(Suppl 1)S56–S60, 2002.
191. Bonow RO, Carabello BA, Kanu C, et al: ACC/AHA
2006 guidelines for the management of patients
with valvular heart disease: A report of the Ameri-
can College of Cardiology/American Heart Asso-
ciation Task Force on Practice Guidelines (Writing
Committee to Revise the 1998 Guidelines for the
Management of Patients with Valvular Heart
Disease): Developed in collaboration with the
Society of Cardiovascular Anesthesiologists: Endor-
sed by the Society for Cardiovascular Angiography
and Interventions and the Society of Thoracic Sur-
geons. Circulation 114(5)e84–e231, 2006.
192. Vandermeulen EP, Van Aken H, Vermylen J: Anti-
coagulants and spinal-epidural anesthesia. Anesth
Analg 79:1165, 1994.
193. Rao TLK, El-Etr AA: Anticoagulation following
placement of epidural and subarachnoid catheters:
An evaluation of neurologic sequelae. Anesthesio-
logy 55:618, 1981.
194. Frame JN, Mulvey KP, Phares JC, Anderson MJ:
Correction of severe heparin-associated throm-
bocytopenia with intravenous immunoglobulin.
Ann Intern Med 111:946, 1989.
195. Waldman SD, Feldstein GS, Waldman HJ, et al:
Caudal administration of morphine sulphate in
anticoagulated and thrombocytopenic patients.
Anesth Analg 66:267, 1987.
196. Bargon HC, LaRaja RD, Rossi G, Atkinson D: Con-
tinuous epidural analgesia in the heparinized vas-
cular surgical patient: A retrospective review of 912
patients. J Vasc Surg 6:144, 1987.
197. Onishchuk JL, Carlsson C: Epidural hematoma asso-
ciated with epidural anesthesia: Complications of
anticoagulant therapy. Anesthesiology 77:1221, 1992.
198. Horlocker TT, Wedel DJ, Offord KP: Does preope-
rative antiplatelet therapy increase the risk of hemo-
rrhagic complications associated with regional
anesthesia? Anesth Analg 70:631, 1990.
199. Macdonald R: Aspirin and extradural blocks. Br J
Anaesth 66:1, 1991.
200. Amrein PC, Ellman L, Harris WH: Aspirin-induced
prolongation of bleeding and perioperative blood
loss. JAMA 245:1825, 1981.
201. Horlocker TT, Wedel DJ, Benzon H, et al: Regional
anesthesia in the anticoagulated patient: Defining
the risks (the second ASRA Consensus Conference
on Neuraxial Anesthesia and Anticoagulation). Reg
Anesth Pain Med 28:172–197, 2003.
202. International Multicentre Trial: Prevention of fatal
postoperative pulmonary embolism by low doses of
heparin. Lancet 2:45, 1975.
203. Consensus Conference: Prevention of venous
thrombosis and pulmonary embolism. JAMA
256:744, 1988.
204. Collins R, Scrimgeour A,Yusuf S, Peto R: Reduction
in fatal pulmonary embolism and venous thrombo-
sis by perioperative administration of subcutaneous
heparin. N Engl J Med 318:1162, 1988.
205. Gallus A, Raman K, Darby T: Venous thrombosis
after elective hip replacement—the influence of
preventive intermittent calf compression and on
surgical technique. Br J Surg 70:17, 1983.
206. Lutz DJ, Noller KL, Spittell JA Jr, et al: Pregnancy
and its complications following cardiac valve pros-
theses. Am J Obstet Gynecol 131:460, 1978.
207. Smith ND, Raizada V,Abrams J: Auscultation of the
normally functioning prosthetic valve. Ann Intern
Med 95:594, 1981.
208. Gauss A, Hübner C, Radermacher P, et al: Periope-
rative risk of bradyarrhythmias in patients with
asymptomatic chronic bifascicular block or left
bundle branch block. Does an additional first-
degree atrioventricular block make any difference?
Anesthesiology 88:679, 1998.
209. Ruskin JN: Catheter ablation for supraventricular
tachycardia. N Engl J Med 324:1660, 1991.
210. Kelly JS, Royster RL: Noninvasive transcutaneous
cardiac pacing. Anesth Analg 69:229, 1989.
211. Risk SC, Brandon D, D’Ambra MN, et al: Indica-
tions for the use of pacing pulmonary artery cat-
heters in cardiac surgery. J Cardiothorac Vasc
Anesth 6:275, 1992.
212. Prystowsky EN: Diagnosis and management of the
pre-excitation syndromes. Curr Probl Cardiol
13:225, 1988.
213. McAnulty JH, Rahimtoola SH, Murphy E, et al:
Natural history of “high-risk” bundle-branch block.
Final report of a prospective study. N Engl J Med
307:137, 1982.
214. Rose MR, Koski G: Anesthesia in patients with
Wolff-Parkinson-White syndrome [abstract].Anes-
thesiology 69:A146, 1988.
215. Anthonisen NR, Connet JE, Kiley JP, et al: Effect of
smoking intervention and the use of an inhaled
anticholinergic bronchodilator on the rate of
decline of FEV1. The Lung Health Study. JAMA
272:1497, 1994.
216. European Respiratory Society: Optimal assessment
and management of chronic obstructive pulmonary
disease (COPD). Eur Respir J 8:1398, 1995.
217. Holleman DR Jr, Simel DL: Does the clinical exami-
nation predict airflow limitation? JAMA 273:313,
1995.
218. Lacasse Y, Guyatt GH, Goldstein RS: The compo-
nents of a respiratory rehabilitation program: A
systematic overview. Chest 111:1077, 1997.
219. Saint S, Bent S, Vittinghoff E, Grady D: Antibiotics
in chronic obstructive pulmonary disease exacerba-
tions. A meta-analysis. JAMA 273:957, 1995.
220. Thompson WH, Nielson CP, Carvalho P, et al: Con-
trolled trial of oral prednisone in outpatients with
acute COPD exacerbations. Am J Respir Crit Care
Med 154:407, 1996.
221. NAEP Expert Panel Report 2: Guidelines for the
diagnosis and management of asthma. Public
Health Service. US Department of Health and
Human Services Publication No. 97-4051A, May
1997. Available at
.
222. Sin DD, Man J, Sharpe H, et al: Pharmacological
management to reduce exacerbations in adults with
asthma: A systematic review and meta-analysis.
JAMA 292:367–376, 2004.
223. Tilles SA: Differential diagnosis of adult asthma.
Med Clin North Am 90:61–76, 2006.
224. Dompeling E, van Schayck CP, van Grunsven PM,
et al: Slowing the deterioration of asthma and
chronic obstructive pulmonary disease observed
during bronchodilator therapy by adding inhaled
corticosteroids. A 4-year prospective study. Ann
Intern Med 118:770, 1993.
225. Calligaro KD, Azurin DJ, Dougherty MJ, et al: Pul-
monary risk factors of elective abdominal aortic
surgery. J Vasc Surg 18:914, 1993.
226. Skolnick ET, Vomvolakis MA, Buck KA, et al:
Exposure to environmental tobacco smoke and the
risk of adverse respiratory events in children recei-
ving general anesthesia. Anesthesiology 88:1144,
1998.
227. Rodgers A, Walker N, Schug S, et al: Reduction of
postoperative mortality and morbidity with epidu-
ral or spinal anaesthesia: Results from overview of
randomised trials. BMJ 321:1493, 2000.
228. Stein M, Cassara EL: Preoperative pulmonary eva-
luation and therapy for surgery patients. JAMA
211:787, 1970.
229. Khan MA, Hussain SF: Review article—pre-opera-
tive pulmonary evaluation. J Ayub Med Coll Abbot-
tabad 17(4)82–86, 2005.
230. Rock P, Passannante A: Preoperative assessment: Pul-
monary. Anesthesiol Clin North Am 22:77–91, 2004.
231. Qaseem A, Snow V, Fitterman N, et al: Risk asses-
sment for and strategies to reduce perioperative
pulmonary complications for patients undergoing
noncardiothoracic surgery: A guideline from the
American College of Physicians. Ann Intern Med
144:575–580, 2006.
232. Smetana GW, Lawrence VA, Cornell JE: Preopera-
tive pulmonary risk stratification for noncardiotho-
racic surery: Systematic review for the American
College of Physicians. Ann Intern Med 144:581–
595, 2006.
233. Collins CD, Darke CS, Knowelden J: Chest com-
plications after upper abdominal surgery: Their
anticipation and prevention. BMJ 1:401, 1968.
234. Warner MA, Offerd KP, Warner ME, et al: Role of
preoperative cessation of smoking and other factors
in postoperative pulmonary complications: A
blinded prospective study of coronary artery bypass
patients. Mayo Clin Proc 64:609, 1989.
235. Robinson K, Conroy RM, Mulcahy R: When does
the risk of acute coronary heart disease in ex-smo-
kers fall to that in non-smokers? A retrospective
study of patients admitted to hospital with a first
episode of myocardial infarction or unstable angina.
Br Heart J 62:16, 1989.
235a. GeertsWH,Bergqvist D,Pineo GF,et al: Prevention of
venous thromboembolism: American College of
Chest Physicians Evidence-Based Clinical Practice
910 Control de la anestesia III